Toyoaki Hida

机构：Saitama International Medical Center, Aichi Cancer Center · ORCID：0000-0003-3537-0020

发表论文 447 篇 · 总被引 29404 次 · h-index 76

代表论文

• Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 158)
• Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study (2025 · Journal of Clinical Oncology · 被引 69)
• International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease (2023 · Translational Lung Cancer Research · 被引 32)
• First‐line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non‐squamous non‐small cell lung cancer: Updated survival analysis of the ONO ‐4538‐52/ TASUKI ‐52 randomized controlled trial (2023 · Cancer Medicine · 被引 26)
• Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial (2024 · JTO Clinical and Research Reports · 被引 14)
• The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review (2024 · Translational Lung Cancer Research · 被引 12)